uvstocks.io

Today’s CSR movers

SRE 4.1 ▲ 1.2

CSX 4.0 ▲ 1.2

AEE 4.0 ▲ 1.2

PCG 4.1 ▲ 1.2

SO 3.1 ▲ 0.8

NKE 3.2 ▼ 0.4

GS 2.4 ▼ 0.8

EIX 2.3 ▼ 0.8

CMCSA 2.3 ▼ 0.8

FOX 2.4 ▼ 1.5

Health Care · NYSE NYSE · SOLV

Solventum

$80.47 +$2.53 +3.15% CLOSE 07.27.26 AFTER HOURS $80.47

Convergence score

3.6 / 5.0 BULLISH

+0.0 vs last report

Overall valuation

Undervalued

Aggregated across multiple horizons

Consensus target (12mo)

$82.89 +3.0%

Range $50.00 — $100.00

Sector

Health Care

NYSE · Tracked daily

Today's snapshot

Where the signals stand.

REPORT 07.27.26

UV Convergence Score

REPORT 07.27.26

3.6

/ 5.0

BULLISH

Consensus signal A

4.0

Consensus signal B

3.0

Consensus signal D

4.0

Rating trend signal

3.6

Analyst average

3.7

Multi-signal aggregate How CSR works →

Day Range

$78.89 – $81.07

52W Range

$62.38 – $88.20

Volume

808.8K

Avg Vol

1.7M

Mkt Cap

$13.94B

P/E

9.85

EPS (TTM)

$8.17

Div Yield

—

Beta

0.72

Today's convergence

Convergence score sits at 3.6 with overall valuation reading as undervalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation

Undervalued

CSR direction

BULLISH

Last close

$80.47

Sector

Health Care

Valuation

Three horizons

UPDATED 07.27.26

Short term

0–3 MO

No target Moderate Buy

Medium term

3–12 MO

$82+1.8% Hold

Long term

12–36 MO

$127.59+58.6% Undervalued

Open valuation →

Analysts

Coverage & consensus

4 PANELS

Mean target (12mo)

$82.89 +3.0%

RANGE $50.00 — $100.00

Analyst consensus

Consensus rating Buy

Blended score 3.6 / 5

Analysts tracked 57

Open analysts →

Financials

Key metrics

LATEST

P/E

9.85

EPS (TTM)

$8.17

Mkt Cap

$13.94B

Div Yield

—

Beta

0.72

52W Range

$62.38 – $88.20

Open financials →

Reports

Valuation breakdown

Three horizons, one consensus.

UPDATED 07.27.26

Short term

0–3 MO

Moderate Buy

Consensus target

No target available

Current analyst consensus rating from Barchart.

Medium term

3–12 MO

Hold

Consensus target

$82 +1.8%

RANGE $50 – $100

$50NOW $80.47$100

12-month analyst consensus target across covering brokerages.

Long term

12–36 MO

Undervalued

Consensus target

$127.59 +58.6%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0

Top-level breakdown

Valuation:	PE Ratio: 9.85	PEG Ratio: -	DE Ratio: -
Free Cash Flow: $377.5M	PB Ratio: -	PS Ratio: -	Dividend: -

Analyst coverage

Blended analyst consensus & targets.

4 PANELS · UPDATED 07.27.26

Analyst consensus RATING · SCORE · PANELS · ANALYSTS

Rating Blended score Panels Analysts

Buy 3.6 4 57

Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE

Coverage Low Mean Median High Upside

All panels $50.00 $82.89 $85.00 $100.00 +3.0%

Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL

Coverage SB B H S SS

All panels 1 12 12 2 1

Rating trend CURRENT VS 1M / 2M / 3M

Period Rating Avg Analysts

Current Moderate Buy 3.63 16

1 Mo Ago Moderate Buy 3.67 15

2 Mo Ago Moderate Buy 3.67 15

3 Mo Ago Moderate Buy 3.57 14

Most recent analyst action LATEST DESK ACTION

Date

7/17/2026

Firm

Weiss Ratings

Action

Upgrade

Rating

Hold (C) ➝ Hold (C+)

Target

—

Full financial snapshot.

UPDATED 07.27.26

Quote snapshot 15 FIELDS

Prev Close

$78.01

Open

$78.77

Day Low

$78.89

Day High

$81.07

Bid

$75.00

Ask

$81.10

52W Low

$62.38

52W High

$88.20

50D Avg

$77.30

200D Avg

$74.91

Volume

808.8K

Avg Vol

1.7M

10D Avg Vol

886.6K

52W Change

5.75%

S&P 52W Change

16.00%

Valuation ratios 10 FIELDS

P/E (TTM)

9.85

P/E (Fwd)

11.36

PEG (Fwd)

1.22

P/S

1.69

P/B

2.81

Book Value

$28.64

EV/Revenue

2.26

EV/EBITDA

16.61

Mkt Cap

13.94B

Enterprise Val

18.67B

Profitability & returns 6 FIELDS

Profit Margin

17.33%

Gross Margin

53.65%

Operating Margin

5.58%

EBITDA Margin

13.60%

Return on Assets

2.75%

Return on Equity

34.79%

Growth 3 FIELDS

Revenue Growth (YoY)

-3.00%

Earnings Growth (YoY)

-91.00%

Earnings Growth (Q)

-90.50%

Balance sheet & cash flow 11 FIELDS

Total Revenue

8.26B

EBITDA

1.12B

Total Cash

561M

Total Debt

5.29B

Cash / Share

$3.24

Revenue / Share

$47.42

Free Cash Flow

377.5M

Operating CF

151M

Debt / Equity

106.48

Current Ratio

1.07

Quick Ratio

0.52

Dividend 5 FIELDS

Fwd Dividend

—

Dividend Yield

—

Payout Ratio

0.00%

5Y Avg Yield

—

Ex-Div Date

—

Share statistics 7 FIELDS

Shares Out

173.17M

Float

147.07M

Shares Short

4.3M

% Short of Float

2.92%

Short Ratio

3.34

% Held Insiders

15.07%

% Held Institutions

76.36%

Calendar & events 5 FIELDS

Next Earnings

2026-08-05

Fiscal Year End

2025-12-31

Most Recent Qtr

2026-03-31

Last Split

—

Split Date

—

Company 2 FIELDS

Industry

Medical Instruments & Supplies

Employees

20,584